Fig. 2From: Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort studyKaplan–Meier analysis according to different diabetic status (a), different PCSK9 levels (b), and status of both PCSK9 levels and diabetic status (c). PCSK9 proprotein convertase subtilisin/kexin type 9, non-DM non-diabetes mellitus, DM diabetes mellitusBack to article page